AOP 3.13% 33.0¢ apollo consolidated limited

I am seriously considering investing in this company. However,...

  1. 831 Posts.
    I am seriously considering investing in this company. However, there are other needle free insulin options on the market. Such as Glygard, chlorpropamide, glibenclamide, glipizide, gliquidone, glymidine, tolazamide, tolbutamide, pioglitazone, rosiglitazone, repaglinide, Oral-Lyn, Advantajet, insulinjet, Medi-Jector Vision, Diamaxol capsules and many more. How is AOP going to compete with them?
 
watchlist Created with Sketch. Add AOP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.